Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sovaldi
Sovaldi
Drugmakers say Japan R&D spending at risk after government forces price cuts
Yahoo/Reuters
Fri, 04/1/16 - 09:25 am
Japan
R&D
Gilead Sciences
Sovaldi
Patent Payoff? Merck's and Ionis Pharmaceuticals' Take Could Be Tiny
Motley Fool
Sat, 03/26/16 - 01:04 pm
Merck
Gilead Sciences
Ionis Pharmaceuticals
hepatitis C
patents
Harvoni
Sovaldi
Gilead to Pay Merck $200 Million in Damages Over Hepatitis C Drug Patents
WSJ Online
Fri, 03/25/16 - 09:42 am
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
Merck
Patent Troubles Hit Biogen After Gilead, Regeneron; What’s Next?
Bidness, ETC
Fri, 03/25/16 - 09:39 am
Biogen
Gilead
Regeneron
patents
Tecfidera
Harvoni
Sovaldi
Gilead has taken a lot of hits lately. Here’s what it really has to fear
Stat
Thu, 03/24/16 - 04:35 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead's CEO: We are appealing the case
CNBC
Thu, 03/24/16 - 09:29 am
Gilead Sciences
patents
Merck
John Milligan
Harvoni
Sovaldi
hepatitis C
Gilead May Have to Pay Rival Merck Billions in Royalties
Fortune
Wed, 03/23/16 - 04:04 pm
Gilead Sciences
Merck
patents
sofosbuvir
Harvoni
Sovaldi
hepatitis C
Merck wins major victory in hep C patent case against Gilead
BioPharma Dive
Wed, 03/23/16 - 09:45 am
Merck
hepatitis C
patents
Gilead Sciences
sofosbuvir
Harvoni
Sovaldi
Gilead And The $3 Billion Merck Issue
Seeking Alpha
Fri, 03/18/16 - 11:10 am
Gilead Sciences
Merck
patents
hepatitis C
Harvoni
Sovaldi
Gilead (GILD) Stock Gains, Owns 94% of Hepatitis-C Market
TheStreet.com
Sat, 03/12/16 - 09:39 am
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
Gilead, Merck Spar Over Hepatitis C $1,000-Pill Royalties
Bloomberg
Mon, 03/7/16 - 09:58 pm
Gilead Sciences
Merck
hepatitis C
Sovaldi
Harvoni
Gilead's 3 Most Profitable Lines of Business
Investopedia
Mon, 03/7/16 - 09:44 am
Gilead Sciences
Truvada
Sovaldi
Harvoni
hepatitis C
hepatitis B
HIV
Gilead: Hep C Prescriptions Hold at 94% Among New Patients
Barron's
Fri, 03/4/16 - 02:48 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
His Job Is to Sell a $1,000 Pill for $10 Without Losing Money
Bloomberg
Mon, 02/29/16 - 10:32 am
Gilead Sciences
Sovaldi
drug pricing
Gilead Faces Troubled HCV Scripts as AbbVie Scripts Go Up
Bidness, ETC
Wed, 12/30/15 - 07:07 pm
Gilead Sciences
AbbVie
hepatitis C
Sovaldi
Harvoni
Viekira Pak
The Price Keeps Falling For a Superstar Gilead Drug in India
Bloomberg
Tue, 12/29/15 - 09:33 am
India
Gilead Sciences
sofosbuvir
Sovaldi
hepatitis C
Sovaldi is expensive, but this drug cost N.C. Medicaid even more
Bizjournals.com
Wed, 12/16/15 - 10:55 am
Sovaldi
Gilead Sciences
drug pricing
North Carolina
Medicaid
Otsuka
Abilify
Gilead Sciences: Hep-C ‘Tracking Fine’ But What About 2016?
Barron's
Fri, 12/4/15 - 08:22 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead considered $115K price for Sovaldi, Senate investigation says
Fierce Pharma
Wed, 12/2/15 - 05:52 pm
Gilead Sciences
Sovaldi
drug pricing
hepatitis C
Senate
Gilead Sciences Inc. Has Plenty of Room to Run in Hepatitis C
Motley Fool
Sat, 11/21/15 - 12:18 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »